Sponsored by:

Molecular Imaging: Page 31

PET confirms efficacy of first-line cardiac sarcoidosis treatment
By Will Morton
FDG-PET imaging has shown for the first time that prednisolone is a potent therapeutic tool for patients with active cardiac sarcoidosis, according to a recent study in JACC: Cardiovascular Imaging.
July 20, 2023
2017 02 10 15 45 57 410 Heart 400
Ratio Therapeutics highlights first patient treated in FAPI PET trial
By AuntMinnie.com staff writers
Ratio Therapeutics, in collaboration with Lantheus and PharmaLogic, has dosed the first patient in a phase I study investigating a novel fibroblast activated protein inhibitor (FAPI)-targeted radiopharmaceutical for PET imaging.
July 19, 2023
2023 07 20 18 02 2249 Pharmaceutical Manufacturing Scientists 400
PET/CT scans predict outcomes in patients with thyroid cancer
By Will Morton
PET/CT scans in patients with advanced thyroid cancer can predict their response to lenvatinib just one week after they begin treatment -- much faster than contrast-enhanced CT (CECT) exams, according to researchers in Japan.
July 18, 2023
2023 07 19 19 04 6002 2023 07 19 Thyroid Pet 400
DOE Isotope Program adds manganese-54 to catalog
By AuntMinnie.com staff writers
The U.S. Department of Energy Isotope Program (DOE IP) has added manganese-54 (Mn-54) to its product catalog.
July 18, 2023
2018 04 24 20 24 4264 Isotope 400
NorthStar and Bayer reach Ac-225 supply deal
By AuntMinnie.com staff writers
NorthStar Medical Isotopes will supply Bayer with the medical radioisotope actinium-225 (Ac-225).
July 18, 2023
2018 12 11 00 02 7009 Atom Nuclear Lab 400
CMS proposal covers PET scans for Alzheimer’s disease
By Will Morton
The U.S. Centers for Medicare and Medicaid Services (CMS) has proposed coverage of amyloid PET scans for diagnosing and managing patients with Alzheimer’s disease, with a 30-day public comment period that opened July 17.
July 17, 2023
2020 07 01 22 14 2802 Washington Dc Capitol 400
New scheme proposed for diagnosing Alzheimer's disease
By Will Morton
Experts have drafted new diagnostic criteria for Alzheimer's disease to reflect recent advances in the field, according to a July 16 presentation delivered at an international conference.
July 17, 2023
2022 08 01 18 21 3281 Brain Amyloid Plaque Neuron 400
Canada grapples with shortage of SPECT agent
By Will Morton
Due to production delays, Canada is facing a shortage of dypyridamole -- an agent used in SPECT myocardial perfusion imaging (MPI) to diagnose coronary artery disease.
July 17, 2023
2017 04 03 18 01 52 418 Graph Arrow Down 400
How should patients manage Lu-PSMA-617 waste disposal?
By Will Morton
A medical physicist in Iowa has crunched the numbers and determined the safest approach for prostate cancer patients receiving Lu-PSMA-617 (Pluvicto) to dispose of their radioactive urine, according to a recent communication in the Journal of Nuclear Medicine.
July 16, 2023
2016 09 08 13 50 18 153 Radiation Symbol Circle 400
Is PSMA PET/CT cost-effective for primary staging?
By Will Morton
PET/CT scans in patients with prostate cancer may increase costs in Europe and the U.S., yet these costs may be reasonably low compared to the potential expenses of an inaccurate diagnosis, according to a recent study.
July 13, 2023
2019 04 17 20 48 2514 Prostate 3 D 400
Male orgasms stimulate the brain's opioid system
By Will Morton
PET brain imaging has revealed a potential treatment target for men with orgasm disorders, with scans revealing that orgasms activate the brain's opioid system, according to a group in Finland.
July 13, 2023
2023 07 13 19 49 6328 2023 07 14 Pet Orgasm 400
Pluvicto patient response criteria validated
By Will Morton
Doctors now have a reliable approach for determining whether prostate cancer patients are responding to prostate cancer treatment with Pluvicto, according to research published July 11 in Radiology.
July 11, 2023
2023 07 12 00 54 5326 2023 07 12 Recip 20230712000635
Previous Page
Page 31 of 612
Next Page